Immuno-Oncology Outlook: PD-1 Data Emerges In Cervical Cancer

 
• By Lucie Ellis-Taitt

Leading immunotherapy agents are beginning to report early-stage data from monotherapy and combination trials in advanced cervical cancer – a treatment area with very few approved options.

Growth
new immunotherapy options are emerging in the cervical cancer pipeline • Source: Shutterstock

More from Immuno-oncology

More from Anticancer